Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer

Update Il y a 4 ans
Reference: NCT00004207

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of liposomal daunorubicin in treating patients who have metastatic breast cancer.


Inclusion criteria

  • Breast Cancer

Links